# Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity

> **NCT07387679** · NA · COMPLETED · sponsor: **Muhammad Aamir Latif** · enrollment: 60 (actual)

## Conditions studied

- Polycystic Ovarian Syndrome

## Interventions

- **DRUG:** Myo-inositol
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT07387679
- **Lead sponsor:** Muhammad Aamir Latif
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-29
- **Primary completion:** 2025-05-28
- **Final completion:** 2025-05-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07387679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07387679, "Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07387679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*